Breaking News Instant updates and real-time market news.

IPSC

Century Therapeutics

$27.75 /

+0.4 (+1.46%)

07:47
07/13/21
07/13
07:47
07/13/21
07:47

BofA starts Century Therapeutics at Buy with $34 price target

As previously reported, BofA analyst Geoff Meacham initiated coverage of Century Therapeutics with a Buy rating and $34 price target. Century's platform uses induced pluripotent stem cells, or iPSCs, to develop chimeric antigen receptor-NK cells and CAR-T cells s for oncology, noted Meacham. Century is "one of just a few companies pushing the leading edge of NK cell therapy" and its platform could be "among the leaders in the gene / cell therapy space," added the analyst.

  • 18

    Jun

IPSC Century Therapeutics
$27.75 /

+0.4 (+1.46%)

07/13/21 BofA
Century Therapeutics initiated with a Buy at BofA
07/13/21 Piper Sandler
Century Therapeutics initiated with an Overweight at Piper Sandler

TODAY'S FREE FLY STORIES

Hot Stocks
Valvoline launches hybrid, EV products in China » 08:42
10/25/21
10/25
08:42
10/25/21
08:42
VVV

Valvoline

$35.28 /

+0.075 (+0.21%)

Valvoline recently…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
VVV Valvoline
$35.28 /

+0.075 (+0.21%)

VVV Valvoline
$35.28 /

+0.075 (+0.21%)

10/13/21
Fly Intel: Top five analyst upgrades
10/13/21 Monness Crespi
Valvoline price target raised to $40 from $36 at Monness Crespi
10/13/21 JPMorgan
JPMorgan sees 'good sum of the parts argument' for Valvoline
10/13/21 Seaport Global
Valvoline upgraded to Buy from Neutral at Seaport Global
VVV Valvoline
$35.28 /

+0.075 (+0.21%)

VVV Valvoline
$35.28 /

+0.075 (+0.21%)

VVV Valvoline
$35.28 /

+0.075 (+0.21%)

VVV Valvoline
$35.28 /

+0.075 (+0.21%)

Hot Stocks
Toll Brothers Campus Living, CanAm Enterprises form join venture » 08:42
10/25/21
10/25
08:42
10/25/21
08:42
TOL

Toll Brothers

$60.46 /

-0.48 (-0.79%)

Toll Brothers, through…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
TOL Toll Brothers
$60.46 /

-0.48 (-0.79%)

TOL Toll Brothers
$60.46 /

-0.48 (-0.79%)

10/14/21 JPMorgan
Toll Brothers price target lowered to $61.50 from $72 at JPMorgan
09/27/21 Citi
Toll Brothers price target lowered to $64 from $70 at Citi
08/26/21 BTIG
Toll Brothers backlog remains longest among major public companies, says BTIG
08/26/21 Barclays
Toll Brothers price target raised to $67 from $62 at Barclays
TOL Toll Brothers
$60.46 /

-0.48 (-0.79%)

TOL Toll Brothers
$60.46 /

-0.48 (-0.79%)

TOL Toll Brothers
$60.46 /

-0.48 (-0.79%)

TOL Toll Brothers
$60.46 /

-0.48 (-0.79%)

Hot Stocks
Logiq issues update on Employee Equity Incentive Plan transactions » 08:42
10/25/21
10/25
08:42
10/25/21
08:42
LGIQ

Logiq

$2.24 /

-0.035 (-1.54%)

Logiq provided an update…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
LGIQ Logiq
$2.24 /

-0.035 (-1.54%)

Hot Stocks
MedMen appoints Roz Lipsey as COO » 08:41
10/25/21
10/25
08:41
10/25/21
08:41
MMNFF

MedMen

/

+

MedMen announced the…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
MMNFF MedMen
/

+

MMNFF MedMen
/

+

09/24/21 Canaccord
MedMen upgraded to Hold from Sell at Canaccord
08/18/21 BMO Capital
Tilray announces initial U.S. cannabis pathway via MedMen, says BMO Capital
08/18/21 Cantor Fitzgerald
MedMen upgraded to Neutral from Underweight at Cantor Fitzgerald
08/18/21 Cantor Fitzgerald
MedMen upgraded to Neutral from Underweight at Cantor Fitzgerald
MMNFF MedMen
/

+

Recommendations
Robert Half price target raised to $124 from $118 at BMO Capital » 08:41
10/25/21
10/25
08:41
10/25/21
08:41
RHI

Robert Half

$112.70 /

+2.125 (+1.92%)

BMO Capital analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
RHI Robert Half
$112.70 /

+2.125 (+1.92%)

RHI Robert Half
$112.70 /

+2.125 (+1.92%)

10/22/21 Baird
Robert Half price target raised to $133 from $122 at Baird
07/26/21 BMO Capital
Robert Half price target raised to $106 from $100 at BMO Capital
07/23/21 Truist
Robert Half price target raised to $100 from $85 at Truist
04/26/21 Barclays
Robert Half price target raised to $95 from $85 at Barclays
RHI Robert Half
$112.70 /

+2.125 (+1.92%)

RHI Robert Half
$112.70 /

+2.125 (+1.92%)

RHI Robert Half
$112.70 /

+2.125 (+1.92%)

Hot Stocks
Cassava Sciences citizens petition circulated by traders » 08:41
10/25/21
10/25
08:41
10/25/21
08:41
SAVA

Cassava Sciences

$45.72 /

-0.865 (-1.86%)

A citizen's petition…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
SAVA Cassava Sciences
$45.72 /

-0.865 (-1.86%)

SAVA Cassava Sciences
$45.72 /

-0.865 (-1.86%)

09/23/21 B. Riley
Cassava Sciences data 'reinvigorate' investor confidence, says B. Riley
08/30/21 Cantor Fitzgerald
Cantor suspends rating on Cassava Sciences after allegations about simufilam
08/26/21 B. Riley
B. Riley says buy Cassava on 'numerous inconsistencies' in Citizen Petition
08/25/21 JonesTrading
Cassava addressed most key concerns in lawyer report, says JonesTrading
SAVA Cassava Sciences
$45.72 /

-0.865 (-1.86%)

  • 13
    Nov
SAVA Cassava Sciences
$45.72 /

-0.865 (-1.86%)

SAVA Cassava Sciences
$45.72 /

-0.865 (-1.86%)

SAVA Cassava Sciences
$45.72 /

-0.865 (-1.86%)

Downgrade
Casper Sleep downgraded to Neutral at Wedbush on decreasing financial stability » 08:40
10/25/21
10/25
08:40
10/25/21
08:40
CSPR

Casper Sleep

$4.43 /

-0.19 (-4.11%)

As previously reported,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
CSPR Casper Sleep
$4.43 /

-0.19 (-4.11%)

CSPR Casper Sleep
$4.43 /

-0.19 (-4.11%)

07:42 Today Wedbush
Casper Sleep downgraded to Neutral from Outperform at Wedbush
07/14/21 Goldman Sachs
Casper Sleep initiated with a Sell at Goldman Sachs
04/26/21 Wedbush
Casper Sleep upgraded to Outperform at Wedbush on better path forward
04/26/21 Wedbush
Casper Sleep upgraded to Outperform from Neutral at Wedbush
CSPR Casper Sleep
$4.43 /

-0.19 (-4.11%)

CSPR Casper Sleep
$4.43 /

-0.19 (-4.11%)

Hot Stocks
Antares Pharma announces oral presentation on XYOSTED » 08:40
10/25/21
10/25
08:40
10/25/21
08:40
ATRS

Antares Pharma

$3.73 /

-0.03 (-0.80%)

Antares Pharma announced…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ATRS Antares Pharma
$3.73 /

-0.03 (-0.80%)

ATRS Antares Pharma
$3.73 /

-0.03 (-0.80%)

08/06/21 H.C. Wainwright
Antares Pharma price target raised to $5.50 from $5 at H.C. Wainwright
07/16/21 Truist
Truist starts Antares Pharma with Buy, $7 price target
07/16/21 Truist
Antares Pharma initiated with a Buy at Truist
ATRS Antares Pharma
$3.73 /

-0.03 (-0.80%)

Hot Stocks
Aquestive Therapeutics reports data from Phase 1 trial of AQST-109 » 08:40
10/25/21
10/25
08:40
10/25/21
08:40
AQST

Aquestive Therapeutics

$4.31 /

-0.165 (-3.69%)

Aquestive Therapeutics…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
AQST Aquestive Therapeutics
$4.31 /

-0.165 (-3.69%)

AQST Aquestive Therapeutics
$4.31 /

-0.165 (-3.69%)

06/24/21 Lake Street
Aquestive approval likely by year-end after Libervant NDA, says Lake Street
04/06/21 RBC Capital
Aquestive Therapeutics transferred with an Outperform at RBC Capital
AQST Aquestive Therapeutics
$4.31 /

-0.165 (-3.69%)

Earnings
Genetic Technologies sees 'material uplift' in December quarter revenue growth » 08:39
10/25/21
10/25
08:39
10/25/21
08:39
GENE

Genetic Technologies

$2.87 /

-0.11 (-3.69%)

Commenting on the…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
GENE Genetic Technologies
$2.87 /

-0.11 (-3.69%)

GENE Genetic Technologies
$2.87 /

-0.11 (-3.69%)

GENE Genetic Technologies
$2.87 /

-0.11 (-3.69%)

Hot Stocks
AptarGroup nasal pump system included in first dry eye disease FDA approval » 08:39
10/25/21
10/25
08:39
10/25/21
08:39
ATR

AptarGroup

$127.79 /

-1.235 (-0.96%)

AptarGroup announced that…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
ATR AptarGroup
$127.79 /

-1.235 (-0.96%)

ATR AptarGroup
$127.79 /

-1.235 (-0.96%)

09/13/21 Baird
AptarGroup price target lowered to $135 from $150 at Baird
08/02/21 William Blair
William Blair downgrades AptarGroup after 'underwhelming quarter'
08/02/21 William Blair
AptarGroup downgraded to Market Perform from Outperform at William Blair
04/19/21 Deutsche Bank
AptarGroup price target raised to $162 from $152 at Deutsche Bank
ATR AptarGroup
$127.79 /

-1.235 (-0.96%)

Earnings
Genetic Technologies reports Q1 cash receipts A$850K » 08:37
10/25/21
10/25
08:37
10/25/21
08:37
GENE

Genetic Technologies

$2.87 /

-0.11 (-3.69%)

Commenting on the…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
GENE Genetic Technologies
$2.87 /

-0.11 (-3.69%)

GENE Genetic Technologies
$2.87 /

-0.11 (-3.69%)

GENE Genetic Technologies
$2.87 /

-0.11 (-3.69%)

Hot Stocks
Cheniere and Glencore sign long-term LNG sale and purchase agreement » 08:37
10/25/21
10/25
08:37
10/25/21
08:37
LNG

Cheniere Energy

$105.25 /

-0.65 (-0.61%)

, GLNCY

Glencore

$10.13 /

-0.0055 (-0.05%)

Cheniere Energy (LNG)…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
LNG Cheniere Energy
$105.25 /

-0.65 (-0.61%)

GLNCY Glencore
$10.13 /

-0.0055 (-0.05%)

LNG Cheniere Energy
$105.25 /

-0.65 (-0.61%)

07:09 Today Morgan Stanley
Cheniere Energy price target raised to $132 from $94 at Morgan Stanley
10/22/21 JPMorgan
Cheniere Energy price target raised to $133 from $104 at JPMorgan
10/21/21 Cowen
Cheniere Energy price target raised to $120 from $109 at Cowen
10/06/21 Goldman Sachs
DT Midstream initiated with a Buy at Goldman Sachs
GLNCY Glencore
$10.13 /

-0.0055 (-0.05%)

10/11/21 JPMorgan
Glencore price target raised to ZAR 9,000 from ZAR 8,600 at JPMorgan
10/08/21 Barclays
Glencore price target raised to 425 GBp from 400 GBp at Barclays
09/29/21 Morgan Stanley
Glencore price target raised to 430 GBp from 360 GBp at Morgan Stanley
09/28/21 RBC Capital
Glencore price target raised to 450 GBp from 400 GBp at RBC Capital
LNG Cheniere Energy
$105.25 /

-0.65 (-0.61%)

LNG Cheniere Energy
$105.25 /

-0.65 (-0.61%)

GLNCY Glencore
$10.13 /

-0.0055 (-0.05%)

GLNCY Glencore
$10.13 /

-0.0055 (-0.05%)

LNG Cheniere Energy
$105.25 /

-0.65 (-0.61%)

Recommendations
WSFS Financial price target raised to $54 from $48 at DA Davidson » 08:37
10/25/21
10/25
08:37
10/25/21
08:37
WSFS

WSFS Financial

$55.60 /

+0.13 (+0.23%)

DA Davidson analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
WSFS WSFS Financial
$55.60 /

+0.13 (+0.23%)

WSFS WSFS Financial
$55.60 /

+0.13 (+0.23%)

10/24/21 Keefe Bruyette
WSFS Financial downgraded to Market Perform from Outperform at Keefe Bruyette
08/20/21 Seaport Global
WSFS Financial initiated with a Neutral at Seaport Global
07/30/21 Keefe Bruyette
Bryn Mawr Bank upgraded to Outperform from Market Perform at Keefe Bruyette
07/22/21 Keefe Bruyette
WSFS Financial upgraded to Outperform from Market Perform at Keefe Bruyette
WSFS WSFS Financial
$55.60 /

+0.13 (+0.23%)

WSFS WSFS Financial
$55.60 /

+0.13 (+0.23%)

Upgrade
Wedbush upgrades Regions Financial to Outperform on unwarranted discount » 08:37
10/25/21
10/25
08:37
10/25/21
08:37
RF

Regions Financial

$24.08 /

+0.81 (+3.48%)

As previously reported,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
RF Regions Financial
$24.08 /

+0.81 (+3.48%)

RF Regions Financial
$24.08 /

+0.81 (+3.48%)

07:16 Today Wedbush
Regions Financial upgraded to Outperform from Neutral at Wedbush
09/08/21
Fly Intel: Top five analyst downgrades
09/08/21 Stephens
Regions Financial downgraded to Equal Weight from Overweight at Stephens
07/19/21 Odeon Capital
Regions Financial downgraded to Hold from Buy at Odeon Capital
RF Regions Financial
$24.08 /

+0.81 (+3.48%)

RF Regions Financial
$24.08 /

+0.81 (+3.48%)

Hot Stocks
Exela Technologies announces new DMR solution » 08:37
10/25/21
10/25
08:37
10/25/21
08:37
XELA

Exela Technologies

$1.51 /

-0.13 (-7.95%)

Exela Technologies…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
XELA Exela Technologies
$1.51 /

-0.13 (-7.95%)

XELA Exela Technologies
$1.51 /

-0.13 (-7.95%)

08/31/21 B. Riley
Exela Technologies initiated with a Buy at B. Riley
06/02/21 Cantor Fitzgerald
Exela Technologies initiated with an Overweight at Cantor Fitzgerald
XELA Exela Technologies
$1.51 /

-0.13 (-7.95%)

XELA Exela Technologies
$1.51 /

-0.13 (-7.95%)

XELA Exela Technologies
$1.51 /

-0.13 (-7.95%)

Hot Stocks
Moderna reports interim data from KidCOVE study of COVID-19 vaccine in children » 08:37
10/25/21
10/25
08:37
10/25/21
08:37
MRNA

Moderna

$326.70 /

-12.77 (-3.76%)

Moderna announced interim…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
MRNA Moderna
$326.70 /

-12.77 (-3.76%)

MRNA Moderna
$326.70 /

-12.77 (-3.76%)

10/22/21
Fly Intel: Top five analyst initiations
10/22/21 Deutsche Bank
Moderna initiated with a Sell at Deutsche Bank
10/15/21
Fly Intel: Top five analyst upgrades
10/15/21 Piper Sandler
Moderna upgraded to Overweight from Neutral at Piper Sandler
MRNA Moderna
$326.70 /

-12.77 (-3.76%)

MRNA Moderna
$326.70 /

-12.77 (-3.76%)

MRNA Moderna
$326.70 /

-12.77 (-3.76%)

MRNA Moderna
$326.70 /

-12.77 (-3.76%)

Initiation
Samsung initiated with an Underperform at Bernstein » 08:35
10/25/21
10/25
08:35
10/25/21
08:35
SSNLF

Samsung

$57.75 /

+ (+0.00%)

, MU

Micron

$67.51 /

-1.16 (-1.69%)

Bernstein analyst Mark Li…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
SSNLF Samsung
$57.75 /

+ (+0.00%)

MU Micron
$67.51 /

-1.16 (-1.69%)

SSNLF Samsung
$57.75 /

+ (+0.00%)

08:35 Today Bernstein
Micron initiated with an Underperform at Bernstein
10/12/21 Lynx
Lynx still bearish on Micron, would not be stepping in on long side
06/08/21 Craig-Hallum
Marvell price target raised to $63 from $52 at Craig-Hallum
04/20/21 JPMorgan
NXP Semiconductors seen at JPMorgan as potential M&A target for Samsung
MU Micron
$67.51 /

-1.16 (-1.69%)

08:35 Today Bernstein
Micron initiated with an Underperform at Bernstein
10/19/21 Mizuho
Micron downgraded to Neutral from Buy at Mizuho
10/15/21 BofA
Micron reinstated with a Neutral at BofA
10/15/21 BofA
Micron reinstated with a Neutral at BofA
SSNLF Samsung
$57.75 /

+ (+0.00%)

MU Micron
$67.51 /

-1.16 (-1.69%)

SSNLF Samsung
$57.75 /

+ (+0.00%)

MU Micron
$67.51 /

-1.16 (-1.69%)

SSNLF Samsung
$57.75 /

+ (+0.00%)

MU Micron
$67.51 /

-1.16 (-1.69%)

MU Micron
$67.51 /

-1.16 (-1.69%)

Initiation
Micron initiated with an Underperform at Bernstein » 08:35
10/25/21
10/25
08:35
10/25/21
08:35
MU

Micron

$67.51 /

-1.16 (-1.69%)

, SSNLF

Samsung

$57.75 /

+ (+0.00%)

Bernstein analyst Mark Li…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
MU Micron
$67.51 /

-1.16 (-1.69%)

SSNLF Samsung
$57.75 /

+ (+0.00%)

MU Micron
$67.51 /

-1.16 (-1.69%)

10/19/21 Mizuho
Micron downgraded to Neutral from Buy at Mizuho
10/15/21 BofA
Micron reinstated with a Neutral at BofA
10/15/21 BofA
Micron reinstated with a Neutral at BofA
10/14/21 Goldman Sachs
Micron price target lowered to $88 from $104 at Goldman Sachs
SSNLF Samsung
$57.75 /

+ (+0.00%)

10/12/21 Lynx
Lynx still bearish on Micron, would not be stepping in on long side
06/08/21 Craig-Hallum
Marvell price target raised to $63 from $52 at Craig-Hallum
04/20/21 JPMorgan
NXP Semiconductors seen at JPMorgan as potential M&A target for Samsung
04/06/21 Roth Capital
Netlist target raised to $4 at Roth Capital after milestone Hynix settlement
MU Micron
$67.51 /

-1.16 (-1.69%)

SSNLF Samsung
$57.75 /

+ (+0.00%)

MU Micron
$67.51 /

-1.16 (-1.69%)

SSNLF Samsung
$57.75 /

+ (+0.00%)

MU Micron
$67.51 /

-1.16 (-1.69%)

SSNLF Samsung
$57.75 /

+ (+0.00%)

MU Micron
$67.51 /

-1.16 (-1.69%)

Earnings
First Bancshares reports Q3 EPS ,76c consensus 75c » 08:35
10/25/21
10/25
08:35
10/25/21
08:35
FBMS

First Bancshares

$39.80 /

+0.41 (+1.04%)

Reports Q3 revenue $40M,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
FBMS First Bancshares
$39.80 /

+0.41 (+1.04%)

FBMS First Bancshares
$39.80 /

+0.41 (+1.04%)

06/14/21
Fly Intel: Top five analyst downgrades
06/14/21 DA Davidson
First Bancshares downgraded to Neutral from Buy at DA Davidson
06/07/21 Hovde Group
First Bancshares initiated with a Market Perform at Hovde Group
FBMS First Bancshares
$39.80 /

+0.41 (+1.04%)

FBMS First Bancshares
$39.80 /

+0.41 (+1.04%)

General news
FX Action: USD-CAD » 08:35
10/25/21
10/25
08:35
10/25/21
08:35
$ECON

Economic Data

/

+

FX Action: USD-CAD is…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
$ECON Economic Data
/

+

$ECON Economic Data
/

+

$ECON Economic Data
/

+

Hot Stocks
Akari Therapeutics announces new data with nomacopan » 08:35
10/25/21
10/25
08:35
10/25/21
08:35
AKTX

Akari Therapeutics

$1.69 /

-0.01 (-0.59%)

Akari Therapeutics…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
AKTX Akari Therapeutics
$1.69 /

-0.01 (-0.59%)

AKTX Akari Therapeutics
$1.69 /

-0.01 (-0.59%)

AKTX Akari Therapeutics
$1.69 /

-0.01 (-0.59%)

Hot Stocks
Castle Biosciences acquiring Pittsburgh Life Science Greenhouse's Cernostics » 08:34
10/25/21
10/25
08:34
10/25/21
08:34
CSTL

Castle Biosciences

$62.88 /

-0.09 (-0.14%)

Castle Biosciences is…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
CSTL Castle Biosciences
$62.88 /

-0.09 (-0.14%)

CSTL Castle Biosciences
$62.88 /

-0.09 (-0.14%)

09/03/21 Canaccord
Castle Biosciences price target raised to $52 from $47 at Canaccord
08/10/21 Baird
Castle Biosciences price target raised to $78 from $73 at Baird
06/17/21 Lake Street
Castle Biosciences meetings highlight robust growth prospects, says Lake Street
04/30/21
Fly Intel: Top five analyst initiations
CSTL Castle Biosciences
$62.88 /

-0.09 (-0.14%)

  • 16
    Dec
Recommendations
Western Alliance price target raised to $145 from $120 at DA Davidson » 08:34
10/25/21
10/25
08:34
10/25/21
08:34
WAL

Western Alliance

$122.08 /

+2.95 (+2.48%)

DA Davidson analyst Gary…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
WAL Western Alliance
$122.08 /

+2.95 (+2.48%)

10/24/21 Wells Fargo
Western Alliance price target raised to $150 from $135 at Wells Fargo
10/18/21 BofA
Western Alliance initiated with a Buy at BofA
10/11/21 Jefferies
Western Alliance price target raised to $131 from $116 at Jefferies
10/07/21 Wells Fargo
Western Alliance price target raised to $135 from $120 at Wells Fargo
WAL Western Alliance
$122.08 /

+2.95 (+2.48%)

WAL Western Alliance
$122.08 /

+2.95 (+2.48%)

Hot Stocks
Sharps Compliance acquires Affordable Medical Waste for $2.2M » 08:33
10/25/21
10/25
08:33
10/25/21
08:33
SMED

Sharps Compliance

$7.99 /

-0.03 (-0.37%)

Sharps Compliance…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
SMED Sharps Compliance
$7.99 /

-0.03 (-0.37%)

08/20/21 Barrington
Sharps Compliance price target lowered to $13 from $18 at Barrington
05/06/21 Barrington
Sharps Compliance price target raised to $18 from $15 at Barrington
04/29/21 H.C. Wainwright
Sharps Compliance price target raised to $25 from $18 at H.C. Wainwright
03/23/21 Roth Capital
Sharps Compliance target raised to $16 at Roth Capital on Mailback strength
SMED Sharps Compliance
$7.99 /

-0.03 (-0.37%)

  • 26
    Aug

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.